Pasar al contenido principal

SISTEMAS NANOESTRUCTURADOS MULTIFUNCIONALES CON APLICACIONES BIOMEDICAS, CATALITICAS Y FOTOCATALITICAS MEJORADAS

RTI2018-094322-B-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD REY JUAN CARLOS

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Copper and sulphur co-doped titanium oxide nanoparticles with enhanced catalytic and photocatalytic properties

  • Ortíz-Bustos, Josefa
  • Gómez-Ruiz, Santiago
  • Mazarío-Santa-Pau, Jaime
  • del Hierro, Isabel
  • Pérez Cortés, Yolanda
  • Domine, Marcelo Eduardo
[EN] Copper and sulphur co-doped titanium oxide nanoparticles have been prepared by the sol-gel method to develop versatile catalysts exhibiting enhanced catalytic and photocatalytic properties. Structural, morphological, chemical composition, and optical characterizations of the synthesized titanium oxide nanoparticles have been carried out in order to study the effect of incorporating copper and sulphur on the catalytic and photocatalytic activities of TiO(2)nanoparticles. Optimal incorporation of copper and sulphur to the titanium dioxide nanoparticles promotes the photocatalytic degradation of ciprofloxacin in water under irradiation of UV or visible light. Complete degradation of ciprofloxacin was achieved after 120 min with the 0.4% Cu-0.5% S-TiO(2)photocatalyst using UV and in 90 min applying visible light. Cu-S-TiO(2)nanoparticles also exhibit high activity (94-98% conversion) and excellent recyclability (with no loss of activity after 14 runs) in selective oxidation of thioanisole using H(2)O(2)as an oxidant., We gratefully acknowledge financial support from the MICINN (project RTI2018-094322-B-I00 and CTQ2017-90802-REDT). M. E. D also acknowledges MICINN (PGC2018-097277-B-I00 and SEV-2016-0683) for financial support, and J. M. thanks MINECO (CTQ2015-67592) for his PhD fellowship.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Dual Anticancer and Antibacterial Properties of Silica-Based Theranostic Nanomaterials Functionalized with Coumarin343, Folic Acid and a Cytotoxic Organotin(IV) Metallodrug

  • Ugalde Arbizu, Maider
  • Aguilera Correa, John Jairo
  • García Almodóvar, Victoria
  • Ovejero Paredes, Karina
  • Díaz García, Diana
  • Esteban, Jaime
  • Páez, Paulina L.
  • Prashar, Sanjiv
  • San Sebastián, Eider
  • Filice, Marco
  • Gómez Ruiz, Santiago
Five different silica nanoparticles functionalized with vitamin B12, a derivative of coumarin found in green plants and a minimum content of an organotin(IV) fragment (1-MSN-Sn, 2-MSN-Sn, 2-SBA-Sn, 2-FSPm-Sn and 2-FSPs-Sn), were identified as excellent anticancer agents against triple negative breast cancer, one of the most diagnosed and aggressive cancerous tumors, with very poor prognosis. Notably, compound 2-MSN-Sn shows selectivity for cancer cells and excellent luminescent properties detectable by imaging techniques once internalized. The same compound is also able to interact with and nearly eradicate biofilms of Staphylococcus aureus, the most common bacteria isolated from chronic wounds and burns, whose treatment is a clinical challenge. 2-MSN-Sn is efficiently internalized by bacteria in a biofilm state and destroys the latter through reactive oxygen species (ROS) generation. Its internalization by bacteria was also efficiently monitored by fluorescence imaging. Since silica nanoparticles are particularly suitable for oral or topical administration, and considering both its anticancer and antibacterial activity, 2-MSN-Sn represents a new dual-condition theranostic agent, based primarily on natural products or their derivatives and with only a minimum amount of a novel metallodrug.